Intelligence Profile
Research Papers
Research Papers and Clinical Trials
The research on Melanotan II spans several areas, with recent studies raising safety concerns while others explore potential therapeutic applications.
Safety Concerns
Two recent case reports highlight potential oral health risks. A 2025 case report documented changes in oral mucosa associated with Melanotan II injections, while another study from the same year examined whether Melanotan II nasal spray might be a risk factor for oral mucosal malignant melanoma. These reports suggest a need for careful monitoring of oral health effects, though the evidence base remains limited to individual cases.
Preclinical Research
Animal studies have explored Melanotan II's effects beyond tanning. A 2024 study in male rats used a chronic unpredictable stress model to examine potential antidepressant and anti-stress effects of Melanotan II alongside another ACTH analog called Semax. Other preclinical work has investigated the compound's role in metabolic regulation, including studies on feeding behavior and metabolic signaling pathways.
Chemical and Pharmacological Research
Recent pharmaceutical research has focused on Melanotan II as a tool compound for studying melanocortin receptors (MCRs), which are G protein-coupled receptors involved in various physiological processes. Additionally, a 2024 chemistry study explored new peptide modification techniques using Melanotan II as a model compound.
Current Clinical Trial
One Phase 2 clinical trial is currently recruiting participants to evaluate Melanotan II as an adjunct to narrowband UV-B phototherapy for treating stable nonsegmental vitiligo, a condition causing loss of skin pigmentation.
The evidence base for Melanotan II remains relatively thin, with most studies being preclinical or consisting of individual case reports. The ongoing vitiligo trial represents the most substantial clinical investigation of the compound's therapeutic potential.
Disclaimer: This information is for educational purposes only and should not be considered medical advice. Consult healthcare professionals for medical guidance.